期刊文献+

EGFRmAb抑制口腔鳞癌细胞增殖的研究 被引量:6

Inhibiting Effect of EGFR Monoclonal Antibody on Proliferation of Oral Squamous Cell Carcinoma
暂未订购
导出
摘要 目的研究表皮生长因子受体单克隆抗体(EGFRmAb)对口腔鳞癌细胞增殖的抑制作用及其作用机理。方法对Tca8113舌鳞癌细胞系给予不同浓度的EGFRmAb处理,通过分析细胞生长曲线和克隆形成抑制率,观察EGFRmAb225对舌鳞癌细胞的增殖抑制作用,并通过分析细胞周期再分配及细胞周期相关蛋白p27kip1的表达,探讨其作用机制。结果EGFRmAb可抑制舌鳞癌细胞的增殖和克隆形成,可以导致G1期细胞比例上升和S期细胞比例下降,并使p27kip1的表达上调。结论EGFRmAb可以抑制舌鳞癌细胞的增殖,其机制与细胞的G1期阻滞有关。 Objective To investigate the inhibiting effect of epidermal growth factor receptor(EGFRmAb)on proliferation of oral squamous cell carcinoma(SCC).Methods Tca8113squamous cell carcinoma cell line was treated with different concentration of EGFRmAb.Cell growth curve,clone inhibition rate,cell cycle redistribution and the expression of p27kip1were analyzed.Results EGFRmAb inhibited proliferation of oral SCC,leaded to elevation of cell proportion of G1phase cell,decreased the proportion of S phase cell and upregulated the express of p27kip1.Conclusion EGFRmAb inhibited the proliferation of oral SCC,which related with G1phase arrest of tumor cell.
出处 《上海口腔医学》 CAS CSCD 2003年第3期200-202,共3页 Shanghai Journal of Stomatology
关键词 表皮生长因子 单克隆抗体 增殖 鳞状细胞癌 Epidermal Growth Factor Monoclonal Antibody Proliferation Squamous Cell Carcinoma
  • 相关文献

参考文献5

  • 1刘泰福.实用放射肿瘤学[M].复旦大学出版社,2001.17.
  • 2王明国,王中和.表皮生长因子受体[J].国外医学(分子生物学分册),2002,24(2):82-85. 被引量:28
  • 3Inoue K, Perrotte SP, Davis DW, et al. Paclitaxiel enhance the effects of the anti-epidermal growth factor monoclonal antibody Imclone C225 in mice with metastasis human bladder transitional cell carcinoma[J]. Clin Cancer Res, 2000,6 (11):4874-4884.
  • 4Rivard N, L" Allemain G, Bartek J, et al. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (GO state) in fibroblasts[J]. J Biol Chem, 1996,271(31):18337-18341.
  • 5Mendelsohn J. The epidermal growth factor receptor as a target for cancer therapy[J]. Endocrine-Related Cancer, 2001, 8:3 - 9.

二级参考文献18

  • 1[1]Wells A. Int J Biochem Cell Biol, 1999; 31(6): 637
  • 2[2]Tarun P et al. Arch biochem biophys, 1999;383(2):309
  • 3[3]Lu Z et al. Mol Cell Biol, 2001; 21(12): 4016
  • 4[4]Raymond Eet al. Drugs,2000; 60(suppl 1): 15
  • 5[5]Deb TB et al. J Biol Chem,2001; 276(18): 15554
  • 6[6]Strachan L et al. J Biol Chem,2001; 276(21): 18265
  • 7[7]Yamanaka Y et al. Biochem Biophys Res Commun,2001; 281(2): 373
  • 8[8]Johannessen LE et al. Exp Cell Res, 2000; 260(1):136
  • 9[9]Denning MF et al. Exp Dermatol,2000; 9(3): 192
  • 10[10]BergstromJDetal. ExpCell Res,2000; 259(1):293

共引文献27

同被引文献71

  • 1王中和,RR米列奥,NJ卡西西.头颈部鳞癌术前放疗还是术后放疗——208例临床分析[J].中华放射肿瘤学杂志,1991,0(3):15-18. 被引量:3
  • 2叶金海,邢树忠,吴煜农,周健,龚西騟,张陈平.口腔鳞状细胞癌上皮型钙依赖黏附蛋白及基质金属蛋白酶-2表达的意义[J].口腔医学,2004,24(6):331-333. 被引量:5
  • 3屠规益,徐国镇.头颈晚期肿瘤的围手术期放射治疗[J].中华耳鼻咽喉头颈外科杂志,2005,40(11):801-804. 被引量:13
  • 4陈晓莉 张志愿 等.γ射线照射对钛板周围组织影响的实验研究[J].中华口腔医学杂志,1999,34:207-207.
  • 5[5]Chao KS,Deasy JO,Markman J,et al.A prospective study of salivary function sparing in patients with head and neck cancer receiving intensity modulated or three dimensional radiation therapy:initial result[J].Int J Radiat Oncol Biol Phys,2001,49:907-916.
  • 6[6]Lee N,Xia P,Akazawa P,et al.Intensity modulated radiotherapy in the treatment of nasopharyngeal carcinoma;An update of the UCSF experience[J].Int J Radiat Oncol Biol Phys,2002,53(1):12-22.
  • 7[7]Wendt CD,Peters LJ,Delclos L,et al.Primary radiotherapy in the treatment of stage Ⅰ and Ⅱ oral tongue cancers:Importance of the proportion of therapy delivered with interstitial therapy[J].Int J Radat Oncol Biol Phys,1990,(18):128-131.
  • 8[8]Lefebvre JL,Coche-Dequeant B,Buisset E,et al.Management of early oral cavity cancer[J].Eur J Cancer Oral Oncol,1994,30:216-220.
  • 9[9]Lapeyre M,Bollet MA,Racadot S,et al.Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity,with positive or close margins[J].Head Neck,2004,26:216-223.
  • 10[10]Jeremic B,Shibamoto Y,Stanisavljevic B,et al.Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in local advanced unresectable squamous cell carcinoma of head and neck:a prospective randomized trial[J].Radiother Oncol,1997,43:29-37.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部